Annual report pursuant to Section 13 and 15(d)

Statements of Changes in Securities Subject to Redemption and Stockholders??? Equity (Deficit)

v3.3.1.900
Statements of Changes in Securities Subject to Redemption and Stockholders’ Equity (Deficit) - USD ($)
Preferred Stock Subject to Redemption [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2013 $ 12,413,876 $ 8,888 $ 451 $ 2,059,347 $ (14,832,812) $ (12,764,126)
Balance, shares at Dec. 31, 2013 10,408,652 8,887,500 451,398      
Conversion of notes payable into preferred stock subject to redemption and warrants to purchase common stock $ 660,635     136,733   136,733
Conversion of notes payable into preferred stock subject to redemption and warrants to purchase common stock, shares 621,788          
Issuance of preferred stock subject to redemption and warrants to purchase common stock, net of offering cost of $68,767 $ 2,531,059     482,068   482,068
Issuance of preferred stock subject to redemption and warrants to purchase common stock, net of offering cost of $68,767, shares 2,369,228          
Exercise of options on common stock     $ 14 14,386   14,400
Exercise of options on common stock, shraes     13,986      
Stock-based compensation       707,390   707,390
Cumulative dividends on Series B preferred stock $ 589,462       (589,462) (589,462)
Accretion of discount on Series C preferred stock 8,580       (8,580) (8,580)
Net loss         (2,473,465) (2,473,465)
Balance at Dec. 31, 2014 $ 16,203,612 $ 8,888 $ 465 3,399,924 (17,904,319) $ (14,495,042)
Balance, shares at Dec. 31, 2014 13,399,668 8,887,500 465,384      
Conversion of notes payable into preferred stock subject to redemption and warrants to purchase common stock          
Exercise of options on common stock     $ 5 5,252   $ 5,257
Exercise of options on common stock, shraes     5,104      
Stock-based compensation       2,894,509   2,894,509
Cumulative dividends on Series B preferred stock $ 327,569       (327,569) (327,569)
Accretion of discount on Series C preferred stock $ 63,283       (63,283) $ (63,283)
Exercise of prepaid forward sale of Series B preferred stock        
Exercise of prepaid forward sale of Series B preferred stock, shares 1,469,994          
Conversion of all outstanding preferred stock to common stock   $ (8,888) $ 1,243 7,645  
Conversion of all outstanding preferred stock to common stock, shares   (8,887,500) 1,243,002      
Conversion of all outstanding preferred stock subject to redemption to common stock $ (16,594,464)   $ 2,080 16,592,384   $ 16,594,464
Conversion of all outstanding preferred stock subject to redemption to common stock, shares (14,869,662)   2,079,650      
Common stock subject to repurchase       (180)   (180)
Issuance of common stock upon closing of initial public offering     $ 4,000 19,996,000   20,000,000
Issuance of common stock upon closing of initial public offering, shares     4,000,000      
Issuance of common stock upon closing of common stock purchase agreement     $ 500 999,500   1,000,000
Issuance of common stock upon closing of common stock purchase agreement, shares     500,000      
Commissions and offering costs of initial public offering       (2,551,390)   $ (2,551,390)
Issuance of common stock for commitment fee     $ 189 (189)  
Issuance of common stock for commitment fee, shares     188,864      
Issuance of common stock to supplier     $ 100 415,900   $ 416,000
Issuance of common stock to supplier, shares     100,000      
Net loss         (8,787,771) (8,787,771)
Balance at Dec. 31, 2015 $ 8,582 $ 41,759,355 $ (27,082,942) $ 14,684,995
Balance, shares at Dec. 31, 2015 8,582,004